233 related articles for article (PubMed ID: 17665326)
21. Gene therapy. Clinical potential and relationship to drug treatment.
Whartenby KA; Marrogi AJ; Freeman SM
Drugs; 1995 Dec; 50(6):951-8. PubMed ID: 8612473
[No Abstract] [Full Text] [Related]
22. Gene vaccines.
Maurice J
Mol Med Today; 1995 May; 1(2):64-71. PubMed ID: 17607897
[No Abstract] [Full Text] [Related]
23. Gene therapy. Is the future here yet?
Yaron Y; Kramer RL; Johnson MP; Evans MI
Obstet Gynecol Clin North Am; 1997 Mar; 24(1):179-99. PubMed ID: 9086525
[TBL] [Abstract][Full Text] [Related]
24. Gene-based vaccines and immunotherapeutic strategies against neurodegenerative diseases: Potential utility and limitations.
Kudrna JJ; Ugen KE
Hum Vaccin Immunother; 2015; 11(8):1921-6. PubMed ID: 26125436
[TBL] [Abstract][Full Text] [Related]
25. Gene therapy for neurodegenerative diseases.
O'Connor DM; Boulis NM
Trends Mol Med; 2015 Aug; 21(8):504-12. PubMed ID: 26122838
[TBL] [Abstract][Full Text] [Related]
26. Why bother? Is in utero gene therapy worth the effort?
Coutelle C
Mol Ther; 2008 Feb; 16(2):219-20. PubMed ID: 18223544
[No Abstract] [Full Text] [Related]
27. From genes to gene medicines: recent advances in nonviral gene delivery.
Rolland AP
Crit Rev Ther Drug Carrier Syst; 1998; 15(2):143-98. PubMed ID: 9592627
[TBL] [Abstract][Full Text] [Related]
28. Notable advances 2016.
Stower H; Bondar T; Farrell A; Basson M; Levinson R; Borowski C; Carmona J; Benedetti B
Nat Med; 2016 Dec; 22(12):1374-1376. PubMed ID: 27923031
[No Abstract] [Full Text] [Related]
29. Breaking the Barriers of Genetic and Metabolic Disorders.
Büning H; Bosch F; Mingozzi F
Hum Gene Ther; 2019 Oct; 30(10):1177-1179. PubMed ID: 31573872
[No Abstract] [Full Text] [Related]
30. American Society of Gene & Cell Therapy--13th Annual Meeting.
Romano G
IDrugs; 2010 Jul; 13(7):444-7. PubMed ID: 20582867
[TBL] [Abstract][Full Text] [Related]
31. A call for physiopathological ethics.
Lowenstein PR
Mol Ther; 2008 Nov; 16(11):1771-2. PubMed ID: 18956015
[No Abstract] [Full Text] [Related]
32. Molecular therapeutics for heritable skin diseases.
Uitto J
J Invest Dermatol; 2012 Nov; 132(E1):E29-34. PubMed ID: 23154630
[No Abstract] [Full Text] [Related]
33. International Society for Cell and Gene Therapy of Cancer (ISCGT) annual meeting: conference overview and introduction to the symposium papers.
Guinn BA; Norris JS; Huang L; Farzaneh F; Kasahara N; Deisseroth AB
Cancer Immunol Immunother; 2006 Nov; 55(11):1406-11. PubMed ID: 16783577
[No Abstract] [Full Text] [Related]
34. Are we ready for clinical gene therapy?
Slavkin HC
J Am Dent Assoc; 1996 Mar; 127(3):396-7. PubMed ID: 8819788
[No Abstract] [Full Text] [Related]
35. The seventh annual meeting of the American Society of Gene Therapy.
Frederickson RM
Mol Ther; 2004 Aug; 10(2):209-10. PubMed ID: 15338572
[No Abstract] [Full Text] [Related]
36. Recent advances in the rational design of silica-based nanoparticles for gene therapy.
Niut Y; Popatt A; Yu M; Karmakar S; Gu W; Yu C
Ther Deliv; 2012 Oct; 3(10):1217-37. PubMed ID: 23116013
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases.
Khan FA; Pandupuspitasari NS; Chun-Jie H; Ao Z; Jamal M; Zohaib A; Khan FA; Hakim MR; ShuJun Z
Oncotarget; 2016 Aug; 7(32):52541-52552. PubMed ID: 27250031
[TBL] [Abstract][Full Text] [Related]
38. Excitement in gene therapy!
Anderson WF
Hum Gene Ther; 2001 Aug; 12(12):1483-4. PubMed ID: 11506691
[No Abstract] [Full Text] [Related]
39. Clinical potential of gene therapy: towards meeting the demand.
Macpherson JL; Rasko JE
Intern Med J; 2014 Mar; 44(3):224-33. PubMed ID: 24621283
[TBL] [Abstract][Full Text] [Related]
40. Gene therapy in the United States: a five-year status report.
Ross G; Erickson R; Knorr D; Motulsky AG; Parkman R; Samulski J; Straus SE; Smith BR
Hum Gene Ther; 1996 Sep; 7(14):1781-90. PubMed ID: 8886849
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
